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track trends on an individual and group basis. Therefore,
developing new methods to improve our data prepares us
better for challenges of external audits, such as CIBMTR and
FACT (Foundation for the Accreditation of Cellular Therapy).
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Signature Authentication
Elizabeth Nista. Blood & Marrow Transplant Program, Medical
University of South Carolin, Charleston, SC
Introduction: The written signature as a validation tool has
not kept up with the electronic age. Written signatures are
cumberson, difﬁcult to verify, easy to forge or pre date, and
inﬂexible for staff.
The clinicians signature is a requirement of multiple
accrediting bodies (most notably the Foundation for the
Accreditation of Cellular Therapy), and is needed for internal
and external written agreements, audits, validations, SOPs,
orders and consents. The handwritten signature is an inef-
ﬁcient use of time and with multiple items needed for
signature can be extremely cumbersome. The DM and QM
staff must wait for the document to be reviewed, (either in
the moment or leave the document with the clinician and
keep checking back for completion). The handwritten
signature can be easily forged or pre-dated making its
authenticity questionable.
Due to these factors an electronic signature was imple-
mented in our program using an Adobe digital signature
program. This change was reviewed with our legal depart-
ment and accrediting bodies who determined this was an
acceptable, and preferable, format. The change was as simple
as changing preferences electronically and was able to be
communicated to staff through a mass email. Next, the
documents to be signed were converted to PDF ﬁle format.
Those ﬁles were then sent electronically to the signator/s.
The signator/s then reviewed the documents at their leisure
and returned the document to the originator with the elec-
tronic signature applied.
The PDF format of the document ensures that the infor-
mation contained has not been altered. The electronic
signature uses encryption technology to verify the signer's
digital identity. The signature consists of three components,
each of which can be customized; the signature, signature
details (e.g. an email address or business location), and
a watermark. Each signature includes the real time and date
that the signature was applied making post or pre dating
impossible.
Example:
Conclusion: Workﬂow was dramatically improved with
electronic submission, review, and return of all documents
providing increased ﬂexibility on the part of the staff. There
is a new integrity and authenticity to the signatures due toa higher level of security thru the use of encryption and the
use of a real time and date stamp. Staff, auditors, and
inspectors alike can be assured they are viewing the most
current, authentic, version of any document by reviewing the
signature stamp.
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Background: Reporting to the Center for International Blood
and Marrow Transplant Research (CIBMTR) and internal
databases requires process management to ensure accurate
data, validity, reliability, error rate, and outcomes. Status quo
processes that go unchallenged remain inefﬁcient and costly.
Updating our process and targeting best practices has
reduced our critical ﬁeld error rate from 4.2% to 1.7% (CIBMTR
audit, 2008 e 2012). We recommend ﬁve innovative process
areas BMT research centers can begin implementing today
with the goal of continuous process improvement.
Five Areas for Innovation: We are targeting innovation in
the following areas: (a) Technology, (b) Communication (c)
Work ﬂow, (d) Stafﬁng, and (e) Data Reliability.
Technology:
 Converting traditionally paper processes into electronic
data ﬁles and scanning documents into our electronic
medical record.
 Rethinking data storage has increased data security and
saved the department an estimated $934.00 per year.
Communication:
 Establishing standardized internal data collection
forms and information sharing encouraged trans-
parency throughout the clinical team.
 Targeting processes including: lost to follow-up,
CIBMTR research consent, comorbidities and infections,
and Physician sign-off.
Work Flow:
 Identifying both low cost and efﬁcient solutions to
workﬂow barriers.
 Redeﬁning tasks for better time tracking, project
management, and Data Coordinator (DC) training.
 Using student interns to address long term data storage
projects.
Stafﬁng:
 Avoiding costly bad hires and reducing turnover by
selecting DC's with strong research backgrounds.
 Conducting peer interviews to gauge personality ﬁt
with the current research team.
Data Reliability:
 Preventing errors with a multi-level checks and
balances procedure for DC feedback.
 Developing internal training manuals with mutually
exclusive and exhaustive categories to eliminate
disagreements in data coding and entry.
 Future reliability testing to streamline DC training and
increase validity. An intercoder reliability above 80%
will be considered acceptable (Krippendorf, 2007).
